Free Trial

HC Wainwright's Rating of Insmed on 11/4/2026

On November 4, 2026, HC Wainwright updated its outlook on Insmed (NASDAQ:INSM) with the action "Initiated Coverage", setting a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from HC Wainwright

DateCompanyAction
11/13/2026
enCore Energy Corp. stock logo
EU
enCore Energy
Lower Price Target
11/13/2026
United States Antimony Co. stock logo
UAMY
United States Antimony
Lower Price Target
11/13/2026
TMC the metals company Inc. stock logo
TMC
TMC the metals
Lower Price Target
11/13/2026
Westwater Resources, Inc. stock logo
WWR
Westwater Resources
Lower Price Target
11/13/2026
Alumis Inc. stock logo
ALMS
Alumis
Lower Price Target
11/13/2026
Lyell Immunopharma, Inc. stock logo
LYEL
Lyell Immunopharma
Lower Price Target
More Ratings From HC Wainwright